tiprankstipranks
Trending News
More News >
Cellectis S.A. (CLLS)
:CLLS
US Market

Cellectis SA (CLLS) Technical Analysis

Compare
931 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Cellectis S.A.’s (CLLS) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Cellectis S.A. is a Sell.
Cellectis S.A.’s (CLLS) 20-Day exponential moving average is 1.37, while Cellectis S.A.’s (CLLS) share price is $1.51, making it a Buy.
Cellectis S.A.’s (CLLS) 50-Day exponential moving average is 1.39, while Cellectis S.A.’s (CLLS) share price is $1.51, making it a Buy.

Cellectis SA (CLLS) Pivot Points

Apr 26, 2025, 08:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.38
1.40
1.43
1.46
1.49
1.51
1.54
Fibonacci
1.40
1.42
1.43
1.46
1.48
1.49
1.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cellectis SA (CLLS) Moving Averages

Apr 26, 2025, 08:52 AM
Period
Simple
Exponential
MA5
1.45Buy
1.46Buy
MA10
1.43Buy
1.42Buy
MA20
1.33Buy
1.37Buy
MA50
1.34Buy
1.39Buy
MA100
1.53Sell
1.52Sell
MA200
1.80Sell
1.80Sell
Cellectis S.A.’s (CLLS) 10-Day exponential moving average is 1.42, while Cellectis S.A.’s (CLLS) share price is $1.51, making it a Buy.
Cellectis S.A.’s (CLLS) 100-Day exponential moving average is 1.52, while Cellectis S.A.’s (CLLS) share price is $1.51, making it a Sell.
Cellectis S.A.’s (CLLS) stock price is $1.51 and Cellectis S.A.’s (CLLS) 50-day simple moving average is 1.34, creating a Buy signal.
Cellectis S.A.’s (CLLS) stock price is $1.51 and Cellectis S.A.’s (CLLS) 100-day simple moving average is 1.53, creating a Sell signal.
Cellectis S.A.’s (CLLS) stock price is $1.51 and Cellectis S.A.’s (CLLS) 200-day simple moving average is 1.80, creating a Sell signal.

Cellectis SA (CLLS) Technical Indicators

Apr 26, 2025, 08:52 AM
Name
Value
Implied Action
RSI (14)
62.53
Neutral
STOCH (9,6)
73.54
Neutral
STOCHRSI (14)
80.43
Sell
MACD (12,26)
0.04
Sell
ADX (14)
20.94
Neutral
Williams %R
-10.87
Sell
CCI (14)
101.58
Sell
ATR (14)
0.09
-
Ultimate Oscillator
51.42
Neutral
ROC
25.83
Buy
Cellectis S.A.’s (CLLS) Relative Strength Index (RSI) is 62.53, creating a Neutral signal.
Cellectis S.A.’s (CLLS) Trend Strength Indicator (ADX) is 20.94, creating a Neutral signal.
Cellectis S.A.’s (CLLS) Commodity Channel Index (CCI) is 101.58, creating a Sell signal.
Cellectis S.A.’s (CLLS) Price Rate of Change (ROC) is 25.83, creating a Buy signal.

FAQ

Is CLLS a Buy, Hold, or Sell?
Based on CLLS’s technical indicators, CLLS is a Hold.
    What is CLLS’s RSI (14)?
    CLLS’s RSI (14) is 62.53, which suggests CLLS is a Neutral.
      What is CLLS’s MACD?
      CLLS’s MACD is 0.04, which suggests CLLS is a Sell.
        What is CLLS’s 5-day moving average?
        CLLS’s 5-day moving average is 1.45, which suggests CLLS is a Buy.
          What is CLLS’s 20-day moving average?
          CLLS 20-day moving average is 1.33, which suggests CLLS is a Buy.
            What is CLLS’s 50-day moving average?
            CLLS’s 50-day moving average is 1.34, which suggests CLLS is a Buy.
              What is CLLS’s 200-day moving average?
              CLLS’s 200-day moving average is 1.80, which suggests CLLS is a Sell.
                What is CLLS’s Williams % R (14)?
                CLLS’s Williams % R (14) is -10.87, which suggests CLLS is a Sell.
                  What is CLLS’s CCI (14)?
                  CLLS’s CCI (14) is 101.58, which suggests CLLS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis